[
1. World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016. [https://apps.who.int/iris/bitstream/handle/10665/250441/9789241565394-eng.pdf?sequence=1&isAllowed=y.] (access: 3.01.2022)
]Search in Google Scholar
[
2. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021. [https://www.who.int/publications/i/item/9789240037021.] (access:3.01.2022)
]Search in Google Scholar
[
3. Analytical and statistical reference book “Tuberculosis in Ukraine” for 2020. Public Health Center of the Ministry of Health of Ukraine. [https://www.phc.org.ua/sites/default/files/users/user90/TB_surveillance_statistical-information_2020_dovidnyk.pdf.]
]Search in Google Scholar
[
4. Bielogortceva OI, Dotcenko YaI, Rekalova OM, Pobedionna GP, Sivachenko OE. Some features of the immune system in children with local forms of tuberculosis. J Clin Exp Med Res (Ukr). 2015;3(1):70-6.
]Search in Google Scholar
[
5. Feshchenko YuI, Todoriko LD, Kuzhko MM, Humenyuk MI. Pathomorphosis of tuberculosis – the realities of the day and chemioresistance as a sign of it’s progression. Ukr pulmonol Zhurn (Ukr). 2018;2:6-10.10.31215/2306-4927-2018-100-2-6-10
]Search in Google Scholar
[
6. Perez-Velez CM, Marais BJ. Tuberculosis in children. NEJM. 2012;367(4):348-61.10.1056/NEJMra1008049
]Search in Google Scholar
[
7. Nejat S, Buxbaum C, Eriksson M, Pergert M, Bennet R. Pediatric tuberculosis in Stockholm: a mirror to the world. PIDJ. 2012;31(3): 224-7.10.1097/INF.0b013e31823d923c
]Search in Google Scholar
[
8. Sousa GJB, Silva JCO, Queiroz TV, Bravo LG, Brito GCB, Pereira AS, et al. Clinical and epidemiological features of tuberculosis in children and adolescents. Rev Bras Enferm. 2019;72(5):1271-1278.10.1590/0034-7167-2018-0172
]Search in Google Scholar
[
9. Musellim B, Erturan S, Sonmez DE, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220-3.
]Search in Google Scholar
[
10. Belogortseva OI, Sukhanova LA, Shekhter IE, Dotcenko Ya.I, Kolisnyk NS, Kirilova TV, et al. Prevalence of multidrug-resistant tuberculosis in children in Ukraine in the context of the overall incidence of tuberculosis. Ukr Pulmonol J (Ukr). 2019;1: 15-20.
]Search in Google Scholar
[
11. Sankalp Y, Gautam R. Primary extra-pulmonary multidrug resistant tuberculosis of the sternum without HIV Infection. JCDR. 2017;11(1):1-3.
]Search in Google Scholar
[
12. Stosic MB, Sagic L, Simic D, Jovanovic V, Rakic V, Adzic Vukicevic T. Tuberculosis and associated risk factors among children and adolescent population in Serbia: 12 year’s retrospective study. J Infect Dev Ctries. 2021;15(6):818-25.10.3855/jidc.14451
]Search in Google Scholar
[
13. Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)/WHO. Geneva: World Health Organization; 2019. [https://www.paho.org/en/node/69034.]
]Search in Google Scholar
[
14. Management of multidrug-resistant tuberculosis in children: A FIELD GUIDE. Fourth Edition. SENTINEL; 2019. [http://sentinel-project.org/wp-content/uploads/2019/02/Updated_DRTB-Field-Guide-2019-V3.pdf.]
]Search in Google Scholar
[
15. Mozammel MdH, Abdullah-Al-Maruf Md, Abdullah Al Baki, Motiur Rahman AZ. Pattern of childhood tuberculosis in the Outpatient department of a Tertiary level hospital in Dhaka city. IJID. 2020;5(2):23-8.10.11648/j.ijidt.20200502.11
]Search in Google Scholar
[
16. Sakhelashvili M, Kostyk O, Sakhelashvili-Bil O, Piskur Z. Features of the resistant forms of a specific process among children and teenagers from the multidrug-resistant tuberculosis infection foci: clinical picture and diagnostics. Georgian Med News. 2021;11(320):70-6.
]Search in Google Scholar
[
17. Kang W, Yu J, Du J, Yang S. The epidemiology of extrapulmonary tuberculosis in China: A large-scale multicenter observational study. PLOS ONE. 2020;15(8).
]Search in Google Scholar
[
18. Klymnyuk SI, Hryshchuk LA, Vynnychuk MO, Boiko TV, Smachylo IV, Lykhatska GV, et al. Diagnostic chemoresistant mycobacterium tuberculosis in the Ternopil region of Ukraine. Wiad Lek. 2020;73(5):959-62.10.36740/WLek202005122
]Search in Google Scholar
[
19. Lesnic E, Niguleanu A, Ustian A, Todoriko L. Impact of drug resistance on the tuberculosis treatment outcome. Actual Infectology. 2017;5(2):78-84.10.22141/2312-413x.5.2.2017.105319
]Search in Google Scholar
[
20. Shokri M, Najafi R, Niromand J, Babazadeh A, Javanian M, Bayani M, et al. The frequency of risk factors for pulmonary tuberculosis in tuberculosis patients in Babol, Northern Iran, during 2008-2015. Curr Issues Pharm Med Sci. 2018;31(3):144-7.10.1515/cipms-2018-0028
]Search in Google Scholar
[
21. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Pediatric tuberculosis. Lancet Infect Dis. 2008;8(8):498-510.10.1016/S1473-3099(08)70182-8
]Search in Google Scholar
[
22. Soeters M, de Vries AM, Kimpen JLL, Donald PR, Schaaf HS. Clinical features and outcome in children admitted to a TB hospital in the Western Cape – the influence of HIV infection and drug resistance. S Afr Med J. 2005;95(8):602-6.
]Search in Google Scholar
[
23. Political declaration of the high-level meeting of the UN General Assembly on the fight against tuberculosis. New York, United Nations General Assembly; 2018. [https://www.who.int/tb/unhlmonTBDeclaration.pdf] (access: 2.08.2019)
]Search in Google Scholar
, 